Wenqiang Li

442 citations
32 papers · 270 indexed · h-index 9
Topics
Liver Disease Diagnosis and Treatment (3 papers)Cerebrovascular and Carotid Artery Diseases (2 papers)Acute Ischemic Stroke Management (2 papers)

In The Last Decade

Wenqiang Li

27 papers receiving 269 citations

Peers

Wenqiang Li
Comparison fields: 5 of 85
  • Molecular Biology 44
  • Social Psychology 40
  • Epidemiology 40
  • Clinical Psychology 36
  • Surgery 31
Replace Mark R. Vesely with:
Mark R. Vesely United States
Robert Wronski Austria
Li Mo China
Justin A. Edward United States
Jasmine Tan United Kingdom
Thorsten Schultheiß Germany
Wenhua Fang China
Han Yang China
Deepa Bhattarai United States
Wenqiang Li relative to Mark R. Vesely United States Mark R. Vesely's profile →
Citations per field
00.5×4.4×
Mark R. Vesely · 1×
Citations per year

Countries citing papers authored by Wenqiang Li

Since Specialization
Citations

This map shows the geographic impact of Wenqiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqiang Li more than expected).

Fields of papers citing papers by Wenqiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqiang Li. The network helps show where Wenqiang Li may publish in the future.

Co-authorship network of co-authors of Wenqiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wenqiang Li. A scholar is included among the top collaborators of Wenqiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenqiang Li. Wenqiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 0
5 2
6 1
7 7
8 10
9 0
10 5
11 13
12 3
13 39
14 10
15 8
16
Atypical Antipsychotic Olanzapine Induces Obese Via an Apoptotic Feedback Pathway
1
17 19
18 29
19 50
20 23

About Wenqiang Li

Wenqiang Li is a scholar working on Immunology, Internal Medicine and Geriatrics and Gerontology, having authored 32 papers that have together received 270 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (3 papers), Cerebrovascular and Carotid Artery Diseases (2 papers) and Acute Ischemic Stroke Management (2 papers). The work is most often cited by research in Internal Medicine (16 citations), Biological Psychiatry (6 citations) and Rehabilitation (15 citations). Wenqiang Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhaohui Zhang, Juan Li, Lin Zhao, Jun Qu, Luxian Lv, Tianzi Jiang, Nan Yao, Xiaoshan Fan, Juntang Lin and Qing Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Hazardous Materials and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026